Outcomes 2012—2016 | LA | TS | p value |
---|---|---|---|
Variables after PSM | n = 36 | n = 16 | |
Euroscore II risk (%) | 2.9 (2.2–5.1) | 3 (2–4.4) | 0.874 |
Cross-clamp time (minutes) | 110 (87–130) | 133 (105–149) | 0.024 |
CPB time (minutes) | 130 (108–154) | 155 (129–172) | 0.049 |
ICU stay (days) | 3 (1–6) | 7 (4–13) | 0.007 |
Atrial fibrillation | 14 (38.9) | 6 (37.5) | 0.924 |
Atrial flutter | 3 (8.3) | 2 (12.5) | 0.637 |
Nodal rhythm | 4 (11.1) | 4 (25) | 0.231 |
AV block | 4 (11.1) | 3 (18.8) | 0.662 |
Sick sinus syndrome | 1 (2.8) | 0 (0) | 1 |
Other SV arrhythmias | 5 (13.9) | 3 (18.8) | 0.689 |
Antiarrhythmic medication | 10 (27.8) | 5 (31.3) | 1 |
Electrical cardioversion | 3 (8.3) | 0 (0) | 0.544 |
Device placement | 5 (13.9) | 7 (10.1) | 1 |
Blood transfusion | 18 (50) | 9 (56.3) | 0.677 |
Creatinine (mg/dL) | 1.3 (1.2–1.6) | 1.3 (1.1–1.6) | 0.959 |
Oral anticoagulation | 13 (36.1) | 6 (37.5) | 0.924 |
Perioperative mortality | 0 (0) | 1 (6.3) | 0.308 |
Post-discharge | |||
SV arrhythmia | 5 (13.9) | 0 (0) | 0.308 |
Device placement | 4 (11.1) | 0 (0) | 0.299 |
Stroke | 0 (0) | 0 (0) | - |
Valve reintervention | 0 (0) | 0 (0) | - |
Chronic oral anticoagulation | 14 (38.9) | 6 (37.5) | 0.924 |
Overall mortality | 2 (5.6) | 1 (6.3) | 1 |